Weakened demand in the RMS segment due to factors in North America and flat spending from the National Institutes of Health.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Weakened demand in the RMS segment due to factors in North America and flat spending from the National Institutes of Health.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
North America
continent in the Americas
-
Charles River Laboratories
major US biomedical company
-
National Institutes of Health
government organization in Shah Alam, Malaysia